Location History:
- Sunnyvale, CA (US) (1997)
- San Rafael, CA (US) (1995 - 1998)
- Los Altos, CA (US) (2000)
- San Jose, CA (US) (2007)
- Los Altos Hills, CA (US) (1998 - 2013)
- Auburn, CA (US) (2019)
Company Filing History:
15 out of 45 
5 out of 5 
4 out of 4 Years Active: 1995-2019
Title: Desmond D Mascarenhas: A Pioneer in Epigenetic Therapeutics
Introduction
Desmond D Mascarenhas, based in Auburn, CA, is an innovative inventor with a remarkable portfolio of 31 patents. His work primarily focuses on the intersection of epigenetics and oxidative stress, offering new insights and therapeutic methods that could profoundly impact medical science.
Latest Patents
One of his latest inventions tackles the modulation of the epigenetic stress response, addressing the serious long-term complications that arise from various forms of stress. This invention introduces a method that utilizes nephrilin peptide, administered through daily subcutaneous bolus injections, to counteract the systemic adverse effects of stress. The significance of this method lies in its capacity to mitigate changes in DNA methylation and histone modifications, which have not been adequately addressed in previous research. Additionally, he has developed methods for generating adaptive biochemical signatures in live cells, aimed at generating diagnostic and therapeutic strategies for human diseases by utilizing provocative agents and measuring adaptive readouts.
Career Highlights
Throughout his career, Mascarenhas has collaborated with notable organizations, including Celtrix Pharmaceuticals, Inc. and Bioexpertise LLC. His innovative approach to epigenetics and therapeutic interventions has led to the development of groundbreaking methodologies that may transform patient outcomes in various medical fields.
Collaborations
In his professional journey, Mascarenhas has worked alongside distinguished coworkers such as Pamela S Olson and David R Olsen, contributing to a dynamic environment of collaborative innovation and research. Together, they have helped advance knowledge in understanding the complexities of stress response and its implications on health.
Conclusion
Desmond D Mascarenhas stands out as a leading figure in the realm of epigenetic research, with a strong emphasis on oxidative stress and its clinical relevance. His contributions through numerous patents illustrate his commitment to advancing medical science and improving human health outcomes, thereby cementing his legacy as a significant inventor in his field.